These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11042721)

  • 21. Shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(9):190-1. PubMed ID: 11905460
    [No Abstract]   [Full Text] [Related]  

  • 22. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
    Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A; Torner N; Martínez A; Costa J; Plans P; Ciruela P; Salleras L
    Vaccine; 2006 Feb; 24(9):1433-7. PubMed ID: 16226357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles immunization in Saudi Arabia: the need for change.
    Khalil MK; Al-Mazrou YY; Al-Jeffri M; Al-Ghamdy YS
    East Mediterr Health J; 2001; 7(4-5):829-34. PubMed ID: 15332786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A special immunization clinic tailors vaccinations].
    Aronsson B; Blennow M
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1675-9. PubMed ID: 18590010
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined vaccine against measles, mumps, rubella and varicella and recommendations for varicella immunization in Italy?].
    Papa R; Spinelli R; Zaratti L; Franco E
    Ig Sanita Pubbl; 2007; 63(6):715-22. PubMed ID: 18216886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging issues in immunization.
    Havaldar PV
    Indian Pediatr; 2002 Jan; 39(1):106-7; author reply 108-11. PubMed ID: 11805368
    [No Abstract]   [Full Text] [Related]  

  • 32. American Academy of Pediatrics. Committee on Infectious Diseases. Age for routine administration of the second dose of measles-mumps-rubella vaccine.
    American Academy of Pediatrics. Committee on Infectious Diseases
    Pediatrics; 1998 Jan; 101(1 Pt 1):129-33. PubMed ID: 11345975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States.
    Kolasa MS; Klemperer-Johnson S; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S98-103. PubMed ID: 15106097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety concerns regarding combination vaccines: the experience in Japan.
    Andreae MC; Freed GL; Katz SL
    Vaccine; 2004 Sep; 22(29-30):3911-6. PubMed ID: 15364439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine vaccines across the life span, 2003.
    Zimmerman RK; Middleton DB; Burns IT; Clover RD
    J Fam Pract; 2003 Jan; 52(1 Suppl):S1-21. PubMed ID: 12556275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(46):1048-50, 1059. PubMed ID: 11105768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MMR vaccination and autism: a lay person's contribution.
    Hamilton M
    West Indian Med J; 2001 Mar; 50(1):87-9. PubMed ID: 11398299
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
    LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P
    Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resumption of routine schedule for diphtheria and tetanus toxoids and acellular pertussis vaccine and for measles, mumps, and rubella vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(27):598-9. PubMed ID: 12143834
    [No Abstract]   [Full Text] [Related]  

  • 40. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.